Vol. XXXV, No. 2 October, 2002

Tom Tenforde

RRS Member Elected President of NCRP

In April, Dr. Thomas Tenforde - a senior chief scientist at the Department of Energy's Pacific Northwest National Laboratory in Richland, Washington - was elected president of the National Council on Radiation Protection and Measurements (http://www.ncrp.com/). Tenforde is the fourth president since the Council (and its predecessor organizations) was formed in 1929.

The NCRP, based in Bethesda, Maryland, has been active in the areas of radiation protection and measurements since its inception as "The Advisory Committee on X-Ray and Radium Protection" in 1929. The NCRP originally operated as an informal association of scientists seeking to make available information and recommendations on radiation protection and measurements. More than 30 major reports were produced during the early period of the NCRP's history including the first recommendation specifying a maximum permissible level of exposure.

With the vast increase in the use of radiation that took place in the 1940s and 1950s, the NCRP's program expanded significantly to meet the new needs and, subsequently, it was recognized that continuation of the informal mode of operation was inappropriate. As a result, the NCRP was reorganized and chartered by the U.S. Congress in 1964 as the National Council on Radiation Protection and Measurements.

Tenforde has more than 30 years of research and management experience in the fields of biological effects of ionizing and nonionizing radiation, environmental and occupational health sciences, medical applications of radiation, surface chemistry of normal and cancer cells, and biological spectroscopy.

Tenforde came to PNNL (www.pnl.gov) in Washington state in 1988. While there, he promoted the production of radioisotopes and isotope products for medical, industrial, and research purposes, and championed work in the environmental and biological sciences.

Since 1995, Tenforde has been developing a multidisciplinary program for the production of radioisotopes and isotope products used in medical diagnostic and therapeutic procedures. The work performed by Tenforde and his staff in producing the medical isotope yttrium-90, which is now being used worldwide for the treatment of cancer, was recently selected for an award as one of the 23 most important new technologies developed with financial support from the U.S. Department of Energy during the 23 years since the Department was formed. In 1999 the production and sales of yttrium-90 was successfully privatized with NEN Life Science Products in Boston, MA, and this accomplishment received a Federal Laboratory Consortium award.

He has authored or co-authored more than 200 journal articles, book chapters and technical reports; participated in national and international professional organizations, and received many awards and recognition for his work.

Tenforde earned a bachelor's degree in physics from Harvard University in 1962 and a doctorate in biophysics from the University of California, Berkeley in 1969.

Tom Tenforde



Return to the October 2002 Table of Contents